| GLOW is a composite research blend incorporating BPC-157 (C₆₂H₉₈N₁₆O₂₂), the copper-peptide complex GHK-Cu (C₁₄H₂₄CuN₆O₄), and TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S).
This formulation is designed to explore multi-pathway interactions in dermal and connective tissue remodeling. GHK-Cu is specifically investigated for its role in collagen and elastin synthesis, while BPC-157 and TB-500 are studied for their angiogenic and cellular repair properties. Researchers utilize this blend to investigate accelerated wound healing models, extracellular matrix reconstruction, and the reduction of oxidative damage in skin tissue substrates. Supplied in a vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption. |
GLOW (5 Pack) ― 70mg
Original price was: $740.00.$555.00Current price is: $555.00.
29 in stock
RELATED PRODUCTS
BPC-157 5mg + TB-500 5mg (3 Pack)
This formulation is a combined research blend consisting of BPC-157 (C₆₂H₉₈N₁₆O₂₂), a partial sequence of body protection compound, and TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S), a synthetic fraction of the protein thymosin beta-4The combination is designed to investigate potential synergistic mechanisms in soft tissue repair models. In experimental settings, these peptides are studied for their distinct but complementary roles in angiogenesis, actin sequestration, and cellular migration. Research applications focus on the acceleration of tendon and ligament healing pathways, reduction of inflammatory markers, and cytoprotection within musculoskeletal systems.
Supplied in a 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption.
Oxytocin Acetate (3 Pack)― 2mg
Oxytocin Acetate (C₄₃H₆₆N₁₂O₁₂S₂) is a cyclic nonapeptide hormone synthesized in the hypothalamus that functions as a fundamental neurotransmitter.
Research focuses on its binding affinity to oxytocin receptors (OXTR) to elucidate pathways governing social bonding, anxiolysis, and physiological contractility. In experimental models, it is used to study the modulation of the hypothalamic-pituitary-adrenal (HPA) axis, stress response attenuation, and trust-building behaviors. As a research reagent, it is critical for investigating neuropeptide signaling in both central and peripheral nervous systems.
Supplied in a 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption.
Sema…― 20mg
Tesamorelin ― 10mg + AOD-9604 ― 5mg
Tesamorelin (C₂₂₁H₃₄₂N₆₂O₆₇) is a chemically modified synthetic analog of growth hormone–releasing hormone (GHRH 1–44) that incorporates a trans-3-hexenoic acid substitution to improve molecular stability. In experimental models, it interacts with GHRH receptors and is used to study mechanisms related to growth hormone production and release. As a research compound, tesamorelin is commonly applied in investigations of peptide–receptor interactions, kinetic stability, and regulation of the somatotropic axis within endocrine and metabolic systems.
AOD-9604 is a peptides fragment originates from residues 177–191 of the human growth hormone sequence and is examined in research for metabolic pathway activity that does not involve IGF-1 signaling. Laboratory studies indicate its effects are associated with regulation of lipid and glucose metabolism, with mechanistic links to β-adrenergic pathways and AMPK-related signaling. It is therefore used as an experimental tool in studies of cellular energy balance, adipocyte development, and metabolic pathway regulation.
Both are supplied in individual 3 mL vial as a lyophilized (freeze-dried) powder requiring reconstitution with a laboratory diluent. For laboratory research use only. Not for human or veterinary consumption.
